Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Breast Neoplasm Female × Carboplatin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 664 Lung Neoplasms 291 Ovarian Neoplasms 281 Breast Neoplasms 235 Fallopian Tube Neoplasms 140 Small Cell Lung Carcinoma 122 Triple Negative Breast Neoplasms 120 Neoplasms 118 Squamous Cell Carcinoma of Head and Neck 108 Carcinoma, Ovarian Epithelial 102 Neoplasm Metastasis 72 Head and Neck Neoplasms 68 Endometrial Neoplasms 63 Esophageal Neoplasms 59 Uterine Cervical Neoplasms 58 Adenocarcinoma of Lung 58 Central Nervous System Neoplasms 46 Brain Neoplasms 46 Recurrence 44 Lymphoma, Large B-Cell, Diffuse 42 Prostatic Neoplasms 41 Carcinoma 41 Neuroblastoma 40 Parkinson Disease 4, Autosomal Dominant Lewy Body 38 Urinary Bladder Neoplasms 37 Esophageal Squamous Cell Carcinoma 36 Lymphoma 34 Carcinoma, Squamous Cell 31 Stomach Neoplasms 29 Melanoma 29

Interventions

venetoclax 1 pyrotinib 1 pertuzumab 1 palbociclib 1 dalpiciclib 1 anlotinib 1 Tretinoin 1 Trastuzumab 1 Ropivacaine 1 Radiosurgery 1 Propofol 1 Paclitaxel 1 Ondansetron 1 Morphine 1 Letrozole 1 Induction Chemotherapy 1 Fulvestrant 1 Etoricoxib 1 Docetaxel 1 Diagnostic Imaging 1 Carboplatin 1 Capecitabine 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06234137 2024-01-31

neoPICD

First Affiliated Hospital of Wenzhou Medical University

Phase NA Recruiting

Breast Neoplasm Female

Data powered by HemOnc (CC BY 4.0) Colophon ⚡